Search - tctmd.com

Displaying 421 - 440 of 1332

Sort: Relevancy | Date

Presentation TCT 2017

SFA Atherectomy for Complex Calcified Lesions: Case Examples and Data

Presenter: Lawrence A. Garcia, Mehdi H. Shishehbor, D. Christopher Metzger

October 30, 2017

Presentation TCT 2017

What Constitutes Optimal Lesion Preparation in the SFA?

Presenter: Lawrence A. Garcia, Mehdi H. Shishehbor, Nicolas W Shammas

October 30, 2017

Presentation TCT 2017

Applications of Coronary CTO Techniques to Peripheral CTOs

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Subhash Banerjee

October 30, 2017

Presentation TCT 2017

Case Conclusion: How I Treated a Long Segment SFA CTO

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Beau Hawkins

October 30, 2017

Presentation TCT 2017

Case Introduction: A Long Segment SFA CTO

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Beau Hawkins

October 30, 2017

Presentation TCT 2017

Maintain Femoral Skills! Rationale and Essential Technique

Presenter: Prashant Kaul, Jennifer A. Tremmel, Curtiss T. Stinis

October 30, 2017

Presentation TCT 2017

Operator and Patient Radiation Exposure: Radial vs Femoral Approach

Presenter: Prashant Kaul, Jennifer A. Tremmel, Alessandro Sciahbasi

October 30, 2017

Presentation TCT 2017

Case Presentation: Management of a Major SFA Dissection

Presenter: Michael Guiry, Julie Logan, Herbert D. Aronow

October 30, 2017

Presentation TCT 2017

SFA Dissections: Implications and Management

Presenter: Michael Guiry, Julie Logan, William A. Gray

October 30, 2017

Presentation TCT 2017

Debate: How should SFA Disease be Treated? In most cases DCB (± BMS)

Presenter: D. Christopher Metzger

October 30, 2017

Presentation TCT 2017

Debate: How should SFA Disease be Treated? In most cases DES!

Presenter: Philip Green

October 30, 2017

Presentation TCT 2017

Case #2: How I Treat Femoral Vein Occlusions (With Discussion)

Presenter: Mahmood K. Razavi, Sanjiv Lakhanpal

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

Presentation TCT 2017

The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® Device

Presenter: Tony Das, Thomas Zeller, William A. Gray

October 30, 2017

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2017

Amit K. Gupta, MBBS, MD

October 26, 2017

News Daily News

Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality

Caitlin E. Cox

October 11, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

Presentation CDM 2017

Femoral CTO: A Stepwise Approach for Recanalization

Presenter: Lawrence A. Garcia

October 05, 2017

Presentation CDM 2017

Transitiong From a CAD to Peripheral Vascular Disease Practice

Presenter: Terry R. Bowers

October 05, 2017

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

Advertisement

SFA Atherectomy for Complex Calcified Lesions: Case Examples and Data

What Constitutes Optimal Lesion Preparation in the SFA?

Applications of Coronary CTO Techniques to Peripheral CTOs

Case Conclusion: How I Treated a Long Segment SFA CTO

Case Introduction: A Long Segment SFA CTO

Maintain Femoral Skills! Rationale and Essential Technique

Operator and Patient Radiation Exposure: Radial vs Femoral Approach

Case Presentation: Management of a Major SFA Dissection

SFA Dissections: Implications and Management

Debate: How should SFA Disease be Treated? In most cases DCB (± BMS)

Debate: How should SFA Disease be Treated? In most cases DES!

Case #2: How I Treat Femoral Vein Occlusions (With Discussion)

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® Device

My Picks for Fellows Attending TCT 2017

Female Surgeons Hold Slight Edge Over Male Peers in Terms of Patients’ 30-Day Mortality

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Femoral CTO: A Stepwise Approach for Recanalization

Transitiong From a CAD to Peripheral Vascular Disease Practice

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content